Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Mesothelioma × Trabectedin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Sarcoma 18 Ovarian Neoplasms 11 Liposarcoma 7 Leiomyosarcoma 7 Neoplasms 6 Sarcoma, Ewing 3 Neoplasm Metastasis 3 Solitary Fibrous Tumors 2 Sarcoma, Synovial 2 Rhabdomyosarcoma 2 Prostatic Neoplasms 2 Liposarcoma, Myxoid 2 Histiocytoma, Malignant Fibrous 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Wilms Tumor 1 Uterine Neoplasms 1 Unspecified Childhood Solid Tumor, Protocol Specific 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Soft Tissue Neoplasms 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Recurrent High Grade Meningioma 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Epithelial Cancer Recurrent 1 Ovarian Diseases 1 Osteosarcoma 1 Neurofibrosarcoma 1

Interventions

Pemetrexed 20 Cisplatin 16 Nivolumab 8 Gemcitabine 7 Ipilimumab 6 Carboplatin 6 tazemetostat 3 pembrolizumab 3 durvalumab 3 Fluorouracil 3 Bevacizumab 3 niraparib 2 budigalimab 2 belinostat 2 anetumab ravtansine 2 Vinorelbine 2 Radiotherapy, Intensity-Modulated 2 Paclitaxel 2 PM 01183 2 Oxaliplatin 2 Imatinib Mesylate 2 Everolimus 2 Erlotinib Hydrochloride 2 Doxorubicin 2 venetoclax 1 tremelimumab 1 trametinib 1 spartalizumab 1 sodium thiosulfate 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02194231 2020-01-23

ATREUS

Mario Negri Institute for Pharmacological Research

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡